Annovis Bio Inc - ESG Rating & Company Profile powered by AI
Jump to the end of this page for potential risks for Annovis Bio Inc based on industry, location and marketcap. If you are employed by Annovis Bio Inc and you wish to use your ESG rating, please contact us. This webpage displays a zero-cost ESG report for Annovis Bio Inc.
Annovis Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.4; made up of an environmental score of 1.6, social score of 0.0 and governance score of 2.7.
1.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2372 | Yifan Pharmaceutical Co Ltd | 1.5 | Low |
| 2372 | iNtRON Biotechnology Inc | 1.5 | Low |
| 2416 | Annovis Bio Inc | 1.4 | Low |
| 2416 | Aerpio Pharmaceuticals Inc | 1.4 | Low |
| 2416 | Anterogen Co Ltd | 1.4 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Annovis Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Annovis Bio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Annovis Bio Inc report the average age of the workforce?
Sign up for free to unlockDoes Annovis Bio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Annovis Bio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Annovis Bio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Annovis Bio Inc offer flexible work?
Sign up for free to unlockDoes Annovis Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Annovis Bio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Annovis Bio Inc conduct supply chain audits?
Sign up for free to unlockDoes Annovis Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Annovis Bio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Annovis Bio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Annovis Bio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Annovis Bio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Annovis Bio Inc disclose water use targets?
Sign up for free to unlockDoes Annovis Bio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Annovis Bio Inc have a product recall in the last two years?
Sign up for free to unlockDoes Annovis Bio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Annovis Bio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Annovis Bio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Annovis Bio Inc disclose parental leave metrics?
Sign up for free to unlockDoes Annovis Bio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Annovis Bio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Annovis Bio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Annovis Bio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Annovis Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Annovis Bio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Annovis Bio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Annovis Bio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Annovis Bio Inc disclose its waste policy?
Sign up for free to unlockDoes Annovis Bio Inc report according to TCFD requirements?
Sign up for free to unlockDoes Annovis Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Annovis Bio Inc disclose energy use targets?
Sign up for free to unlockDoes Annovis Bio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Annovis Bio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Annovis Bio Inc
These potential risks are based on the size, segment and geographies of the company.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.